- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
Veteran strategist Dennis Gartman says it’s still a bear market with no Fed pivot in sight.
August 08, 2022
From MarketWatch
From Benzinga
U.S. Stock Futures Higher After Friday's Jobs Report
August 08, 2022
From Benzinga
From Benzinga
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Official U.S. new case tally may be declining but at-home testing obscures data, and Novavax starts trial of vaccine for very young children
August 05, 2022
From MarketWatch
3 of the Best Bear Market Buys for August
August 05, 2022
From Motley Fool
Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates
August 05, 2022
From Benzinga
A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
August 04, 2022
From Benzinga
Here's Why BioNTech Stock Is Moving
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
Could the Fall Booster Market Boost Vaccine Stocks?
August 02, 2022
From Motley Fool
From Motley Fool
From Benzinga
5 Value Stocks In The Healthcare Sector
August 01, 2022
From Benzinga
Is The Energy Ready To Rebound?
August 01, 2022
From Benzinga
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
July 29, 2022
From MarketWatch
From Motley Fool
From Benzinga
Research shows coronavirus pandemic originated in Wuhan wet market and did not escape from a Chinese lab
July 27, 2022
From MarketWatch
From Motley Fool
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
July 25, 2022
From Benzinga
CDC OK’s Novavax vaccine to add fifth shot to U.S. program, and COVID cases triple in Europe in six-week span
July 20, 2022
From MarketWatch
2 Things Novavax Must Do to Be a Monster Comeback Stock
July 20, 2022
From Motley Fool
Why Moderna Stock Bumped Higher Today
July 19, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.